BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Foray C, Valtorta S, Barca C, Winkeler A, Roll W, Müther M, Wagner S, Gardner ML, Hermann S, Schäfers M, Grauer OM, Moresco RM, Zinnhardt B, Jacobs AH. Imaging temozolomide-induced changes in the myeloid glioma microenvironment. Theranostics 2021;11:2020-33. [PMID: 33500706 DOI: 10.7150/thno.47269] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Quach S, Holzgreve A, Kaiser L, Unterrainer M, Dekorsy FJ, Nelwan DV, Bartos LM, Kirchleitner SV, Weller J, Weidner L, Niyazi M, Ruf VC, Herms J, Stöcklein S, Wetzel C, Riemenschneider MJ, V Baumgarten L, Thon N, Brendel M, Rupprecht R, Bartenstein P, Tonn JC, Albert NL. TSPO PET signal using [(18)F]GE180 is associated with survival in recurrent gliomas. Eur J Nucl Med Mol Imaging 2023;50:859-69. [PMID: 36329288 DOI: 10.1007/s00259-022-06006-1] [Reference Citation Analysis]
2 Xu C, Xiao M, Li X, Xin L, Song J, Zhan Q, Wang C, Zhang Q, Yuan X, Tan Y, Fang C. Origin, activation, and targeted therapy of glioma-associated macrophages. Front Immunol 2022;13:974996. [DOI: 10.3389/fimmu.2022.974996] [Reference Citation Analysis]
3 van der Heide CD, Dalm SU. Radionuclide imaging and therapy directed towards the tumor microenvironment: a multi-cancer approach for personalized medicine. Eur J Nucl Med Mol Imaging 2022. [PMID: 35788730 DOI: 10.1007/s00259-022-05870-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Barca C, Foray C, Zinnhardt B, Winkeler A, Herrlinger U, Grauer OM, Jacobs AH. In Vivo Quantitative Imaging of Glioma Heterogeneity Employing Positron Emission Tomography. Cancers 2022;14:3139. [DOI: 10.3390/cancers14133139] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Quach S, Holzgreve A, von Baumgarten L, Niyazi M, Unterrainer M, Thon N, Stöcklein S, Bartenstein P, Tonn JC, Albert NL. Increased TSPO PET signal after radiochemotherapy in IDH-wildtype glioma-indicator for treatment-induced immune activation? Eur J Nucl Med Mol Imaging 2022. [PMID: 35610517 DOI: 10.1007/s00259-022-05844-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Holzgreve A, Pötter D, Brendel M, Orth M, Weidner L, Gold L, Kirchner MA, Bartos LM, Unterrainer LM, Unterrainer M, Steiger K, von Baumgarten L, Niyazi M, Belka C, Bartenstein P, Riemenschneider MJ, Lauber K, Albert NL. Longitudinal [(18)F]GE-180 PET Imaging Facilitates In Vivo Monitoring of TSPO Expression in the GL261 Glioblastoma Mouse Model. Biomedicines 2022;10. [PMID: 35453488 DOI: 10.3390/biomedicines10040738] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Ng TSC, Allen HH, Rashidian M, Miller MA. Probing immune infiltration dynamics in cancer by in vivo imaging. Curr Opin Chem Biol 2022;67:102117. [PMID: 35219177 DOI: 10.1016/j.cbpa.2022.102117] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Li Y, Liu F, Zhu D, Zhu T, Zhang Y, Li Y, Luo J, Kong L. A new near-infrared excitation/emission fluorescent probe for the detection of β-galactosidase in living cells and in vivo. Talanta 2022;237:122952. [PMID: 34736678 DOI: 10.1016/j.talanta.2021.122952] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Barca C, Foray C, Hermann S, Herrlinger U, Remory I, Laoui D, Schäfers M, Grauer OM, Zinnhardt B, Jacobs AH. The Colony Stimulating Factor-1 Receptor (CSF-1R)-Mediated Regulation of Microglia/Macrophages as a Target for Neurological Disorders (Glioma, Stroke). Front Immunol 2021;12:787307. [PMID: 34950148 DOI: 10.3389/fimmu.2021.787307] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
10 Barca C, Griessinger CM, Faust A, Depke D, Essler M, Windhorst AD, Devoogdt N, Brindle KM, Schäfers M, Zinnhardt B, Jacobs AH. Expanding Theranostic Radiopharmaceuticals for Tumor Diagnosis and Therapy. Pharmaceuticals (Basel) 2021;15:13. [PMID: 35056071 DOI: 10.3390/ph15010013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
11 Žavbi J, Breznik B. Modelling the microenvironment of the most aggressive brain tumours for preclinical studies. Advances in Cancer Biology - Metastasis 2021;3:100017. [DOI: 10.1016/j.adcanc.2021.100017] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Yan P, Li JW, Mo LG, Huang QR. A nomogram combining inflammatory markers and clinical factors predicts survival in patients with diffuse glioma. Medicine (Baltimore) 2021;100:e27972. [PMID: 34964788 DOI: 10.1097/MD.0000000000027972] [Reference Citation Analysis]
13 Ma J, Chen CC, Li M. Macrophages/Microglia in the Glioblastoma Tumor Microenvironment. Int J Mol Sci 2021;22:5775. [PMID: 34071306 DOI: 10.3390/ijms22115775] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
14 Valtorta S, Lo Dico A, Raccagni I, Martelli C, Pieri V, Rainone P, Todde S, Zinnhardt B, De Bernardi E, Coliva A, Politi LS, Viel T, Jacobs AH, Galli R, Ottobrini L, Vaira V, Moresco RM. Imaging Metformin Efficacy as Add-On Therapy in Cells and Mouse Models of Human EGFR Glioblastoma. Front Oncol 2021;11:664149. [PMID: 34012924 DOI: 10.3389/fonc.2021.664149] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Zinnhardt B, Roncaroli F, Foray C, Agushi E, Osrah B, Hugon G, Jacobs AH, Winkeler A. Imaging of the glioma microenvironment by TSPO PET. Eur J Nucl Med Mol Imaging 2021. [PMID: 33721063 DOI: 10.1007/s00259-021-05276-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]